Effects of Essential Oils Extracted from Cnidii Rhizoma on Differentiation and Adipogenesis in 3T3-L1 Adiopocytes

천궁(川芎)의 정유 추출물이 3T3-L1 세포의 분화 및 지방 생성에 미치는 영향

  • Received : 2018.06.13
  • Accepted : 2018.07.05
  • Published : 2018.07.31


Objectives We investigated anti-obesity effects of essential oils extracted from Cnidii Rhizoma (CR) in immature adipocytes to magnify it's clinical therapeutic usage. Methods Essential oil of CR was extracted with ethyl acetate or petroleum ether and through steam distillation, respectively. Oil red-O staining for monitoring its inhibition effect on adipogenesis and differentiation in murine 3T3-L1 adipocytes and 3-(4,5-methylthiazol-2-yl)-2,5-diphenyletetra zolium bromide (MTT) assay for cell safety were done. Also phospho-adenosine monophosphate (AMP)-activted protein kinase (P-AMPK), AMP-activated protein kinase, phospho-acetyl-CoA carboxylase (P-ACC), acetyl-CoA carboxylase, peroxisome proliferator-activated receptor-${\alpha}$ (PPAR-${\alpha}$), peroxisome proliferator-activated receptor-${\gamma}$ (PPAR-${\gamma}$) and CCAAT/enhancer binding protein ${\alpha}$ (C/EBP-${\alpha}$) expressions as obesity-related factors were measured by western blot analysis. Results Protein expressions of P-AMPK, P-ACC and PPAR-${\alpha}$ were increased in essential oils-treated adipocytes compared to those of control group, respectively. Furthermore, protein expressions of PPAR-${\gamma}$ and C/EBP-${\alpha}$ were decreased in essential oils-treated adipocytes compared to those of control group, respectively. Conclusions These results demonstrate that essential oils of CR inhibit adipogenesis and differentiation. Also they promote the oxidation of fatty acids in adipocytes. Thus, results suggest that essential oils of CR could be used as a valuable material for anti-obesity therapeutics via control of lipid metabolism.


Cnidii Rhizoma;Essential oils;Adipogenesis;3T3-L1 cells;Obesity


  1. The Society of Korean Medicine Rehabilitation. Korean Rehabilitation Medicine. 4th ed. Paju:Koonja Publishing. 2015:299-302.
  2. Joo JK. Lee KS. Pharmacotherapy for obesity. J Menopausal Med. 2014;20(3):90-6.
  3. Korean Medical College Society Textbook Compilation Committee. The Herbology. 1st ed. Seoul:Younglimsa. 2008:447-8.
  4. Gong JH. Susebowon. Taipei:Gangupseoguk Co., Ltd. 1987:102-3.
  5. Won HR. Effect of the Cnidium officinale makino water extract on the lipid metabolism of rats fed a hypercholesterol diet. Korean J Community Living Sci. 2015;26(2):351-60.
  6. Yoon BH. The effects of Cnidium officinale makino methanol extract on the control of 3T3-L1 preadipocytes differentiation [dissertation]. Anseong (KR):Graduate School of Hankyong National University; 2011.
  7. Yang YG. Naegyeongsomun-yeakhae. Seoul:Daesung Print. 1990:235-43, 356-61.
  8. Jang JK. Geumgweyoryak. Seoul:Sungbosa. 1985:35.
  9. Kim JM, Choi SM, Yang DH, An HD. The effect of oral administration at herbal medicines in animal models on obesity: a review of animal study reports published in Korea after 2010. J Korean Med Rehabil. 2017;27(3): 13-32.
  10. Jeong JB, Ju SY, Park JH, Lee JR, Yun KW, Kwon ST, Lim JH, Chung GY, Jeong HJ. Antioxidant activity in essential oils of Cnidium officinale makino and Ligusticum chuanxiong hort and their inhibitory effects on DNA damage and apoptosis induced by ultraviolet B in mammalian cell. Cancer Epidemiol. 2009;33(1):41-6.
  11. Choi SW, Kim EO, Leem HH, Kim JK. Anti-inflammatory effects of volatile flavor extracts from Cnidium officinale and Angelica gigas. J Korean Soc Food Sci Nutr. 2012;41(8):1057-65.
  12. Jeong JW, Choi YH, Park C. Induction of apoptosis by ethanol extract of Cnidium officinale in human leukemia U937 cells through activation of AMPK. Journal of Life Science. 2015;25(11):1255-64.
  13. Yoo DH, Joo DH, Lee SY, Lee JY. Antioxidant effect of Nelumbo nucifera G. leaf extract and inhibition of MITF, TRP-1, TRP-2, and tyrosinase expression in a B16F10 melanoma cell line. Journal of Life Science. 2015;25(10):1115-23.
  14. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145-71.
  15. Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta. 2010;1804(3):581-91.
  16. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem. 2006;281(35):25336-43.
  17. Shen QW, Zhu MJ, Tong J, Ren J, Du M. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. Am J Physiol Cell Physiol. 2007;293(4):C1395-403.
  18. Zeqiraj E, Filippi BM, Deak M, Alessi DR, van Aalten DM. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science. 2009;326(5960):1707-11.
  19. Carling D. The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci. 2004;29(1):18-24.
  20. Kim EJ, Jung SN, Son KH, Kim SR, Ha TY, Park MG, Jo IG, Park JG, Choe W, Kim SS, Ha J. Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase. Mol Pharmacol. 2007;72(1):62-72.
  21. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15-25.
  22. Ntambi JM, Kim YC. Adipocyte differentiation and gene expression. J Nutr. 2000;130(12):3122S-6S.
  23. van Tienen FH, Laeremans H, van der Kallen CJ, Smeets HJ. Wnt5b stimulates adipogenesis by activating PPAR gamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a. Biochem Biophys Res Commun. 2009;387(1):207-11.
  24. Gustafson B, Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem. 2006;281(14):9507-16.
  25. Poirier Y, Antonenkov VD, Glumoff T, Hiltunen JK. Peroxisomal beta-oxidation--a metabolic pathway with multiple functions. Biochim Biophys Acta. 2006;1763(12):1413-26.
  26. Frazier-Wood AC, Ordovas JM, Straka RJ, Hixson JE, Borecki IB, Tiwari HK, Arnett DK. The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study. Pharmacogenomics J. 2013;13(4):312-7.
  27. Kelley GL, Azhar S. Reversal of high dietary fructose-induced $PPAR{\alpha}$ suppression by oral administration of lipoxygenase/cyclooxygenase inhibitors. Nutr Metab (Lond). 2005;2:18.
  28. Choi JS, Kim JS, Ali MY, Min BS, Kim GD, Jung HA. Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating $C/EBP-{\alpha}$ and PPAR-${\gamma}$. Fitoterapia. 2014;98:199-208.


Supported by : 한국연구재단